The price of Credo Technology Group Holding Ltd (NASDAQ: CRDO) closed at $15.03 in the last session, up 0.47% from day before closing price of $14.96. In other words, the price has increased by $+0.07 from its previous closing price. On the day, 1728880 shares were traded. CRDO stock price reached its highest trading level at $15.21 during the session, while it also had its lowest trading level at $14.70.
We take a closer look at CRDO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.00 and its Current Ratio is at 10.30. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on August 25, 2023, Reiterated its Market Perform rating but revised its target price to $16 from $14 previously.
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 13 when Brennan William Joseph sold 15,000 shares for $15.48 per share. The transaction valued at 232,260 led to the insider holds 4,017,421 shares of the business.
Brennan William Joseph sold 15,000 shares of CRDO for $236,724 on Sep 12. The Pres & Chief Executive Officer now owns 4,032,421 shares after completing the transaction at $15.78 per share. On Sep 08, another insider, Lam Yat Tung, who serves as the Chief Operating Officer of the company, sold 150,000 shares for $16.07 each. As a result, the insider received 2,411,085 and left with 2,820,000 shares of the company.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRDO now has a Market Capitalization of 2.25B and an Enterprise Value of 2.03B. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.40 while its Price-to-Book (P/B) ratio in mrq is 6.45. Its current Enterprise Value per Revenue stands at 11.76 whereas that against EBITDA is -91.65.
Stock Price History:
Over the past 52 weeks, CRDO has reached a high of $19.46, while it has fallen to a 52-week low of $7.20. The 50-Day Moving Average of the stock is 15.88, while the 200-Day Moving Average is calculated to be 13.44.
According to the various share statistics, CRDO traded on average about 2.08M shares per day over the past 3-months and 1.59M shares per day over the past 10 days. A total of 149.28M shares are outstanding, with a floating share count of 114.70M. Insiders hold about 10.60% of the company’s shares, while institutions hold 47.00% stake in the company. Shares short for CRDO as of Aug 30, 2023 were 7.31M with a Short Ratio of 7.31M, compared to 5.88M on Jul 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 4.87% and a Short% of Float of 6.38%.
The company has Cardiff Oncology, Inc. analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $16.35, with high estimates of $0.96 and low estimates of $15.03.
Analysts are recommending an EPS of between $Healthcare and $Technology for the fiscal current year, implying an average EPS of $Consumer Defensive. EPS for the following year is $Stocks, with Stocks analysts recommending between $Stocks and $Stocks.